← Back to patent-cliff list
ASI-02
Tier C — Watch / tradeASI-02
Agitated Solutions Inc
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
In vivo diagnostic
Type
Targets：Updating
Indications (approved)：Heart disease
Regional status
US
Phase III
2025-04-08
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of ASI-02?
Approved indications include: Heart disease.
When does the ASI-02 patent expire?
No public expiry year is available for ASI-02 yet; this page updates once verified.
How do I get a quote for ASI-02 intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-30